| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $317K | -84.8% |
| Cost of Revenue | $158K | -86.3% |
| Gross Profit | $159K | -82.9% |
| R&D Expense | $36.3M | +36.6% |
| SG&A Expense | $15.6M | +88.7% |
| Operating Income | -$51.7M | -52.7% |
| Pre-tax Income | -$50.5M | -49.3% |
| Income Tax | -$307K | +0.0% |
| Net Income | -$50.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.6M | -3.0% |
| Short-term Investments | $32.9M | -55.7% |
| Accounts Receivable | $12K | -95.0% |
| Current Assets | $108.7M | -28.6% |
| Total Assets | $122.4M | -26.6% |
| Current Liabilities | $8.1M | +43.0% |
| Total Liabilities | $12.5M | +16.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.1M | -42.9% |
| Capital Expenditures | $742K | +1121.5% |
| Investing Cash Flow | $41.8M | +155.3% |
| Financing Cash Flow | $19K | -100.0% |
| Free Cash Flow | -$44.8M | -45.1% |
| -50.6% |
| EPS (Basic) | -$1.91 | +22.4% |
| EPS (Diluted) | -$1.90 | +22.8% |
| Stockholders' Equity |
| $109.9M |
| -29.6% |